id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dpc-5458	Giunta, Alessandro; Esposito, Maria; Campione, Elena; Burlando, Martina ; Caldarola, Giacomo ; Lora, Viviana ; Diotallevi, Federico ; Tolino, Ersilia ; Silvi, Gianmarco; Cozzani, Emanuele; Shumak, Ruslana Gaeta; Fidanza, Rosaria ; Antonetti, Paolo ; Pinto, Lorenzo Maria; Mirisola, Valentina ; Fargnoli, Maria Concetta; Bianchi, Luca ; Prignano, Francesca	Elective First-Line Use of Dimethyl Fumarate in Psoriasis: Insights from an Italian Cohort	2025	10	.pdf	application/pdf	5539	366	56	The analysis also showed that a longer duration of psoriasis was associated with a higher frequency of adverse events upon starting treatment with DMF. DMF treatment was significantly more effective in patients with a disease duration of less than five years after 24 and 48 weeks than in patients with a disease duration of 5–10 or more than 10 years (P=0.04 and P=0.032; Table 5). Patients Patients aged ≥18 years with a diagnosis of moderate psori- asis who underwent DMF treatment for 48 weeks between June 2022 and December 2023, according to standard clini- cal practice, were enrolled in the study.	cache/dpc-5458.pdf	txt/dpc-5458.txt